3,4-dihydroxybenzohydroxamic acid has been researched along with cuprizone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baer, M; Benusa, SD; Clark, KC; Davenne, M; DeVries, GH; Dilsizoglu-Senol, A; Dupree, JL; Elford, H; Hartley, RK; Josephson, A; Joslyn, M; Lubetzki, C; Oh, U; Sword, BA; Thummala, S | 1 |
1 other study(ies) available for 3,4-dihydroxybenzohydroxamic acid and cuprizone
Article | Year |
---|---|
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Topics: Animals; Animals, Genetically Modified; Autoimmune Diseases of the Nervous System; Axon Initial Segment; Axons; CD11b Antigen; Cell Death; Cells, Cultured; Cuprizone; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Hydroxamic Acids; Macrophage Colony-Stimulating Factor; Mice; Mice, Inbred C57BL; Microglia; Monoamine Oxidase Inhibitors; Nitric Oxide Synthase Type II; Thy-1 Antigens; Tumor Necrosis Factor-alpha | 2016 |